CLINICAL TRIAL

Teaching Obesity Treatments to Adult Learners (TOTAL) for Obesity

Waitlist Available · 18+ · All Sexes · West Los Angeles, CA

TOTAL: A Multisite RCT

See full description

About the trial for Obesity

Eligible Conditions
Obesity · Overweight

Treatment Groups

This trial involves 2 different treatments. Teaching Obesity Treatments To Adult Learners (TOTAL) is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.

Main TreatmentA portion of participants receive this new treatment to see if it outperforms the control.
Teaching Obesity Treatments to Adult Learners (TOTAL)
BEHAVIORAL
Control TreatmentAnother portion of participants receive the standard treatment to act as a baseline.
Usual care
BEHAVIORAL

Eligibility

This trial is for patients born any sex aged 18 and older. There is one eligibility criterion to participate in this trial as listed below.

Inclusion & Exclusion Checklist
Mark “yes” if the following statements are true for you:
Veterans will be eligible for this study if they have had no MOVE! visit attendance within the last 12 months, no previous bariatric surgery, not currently on weight loss medications, and a BMI of 30 kg/m2 or 27-29.9 + an obesity-related comorbidity
View All
Odds of Eligibility
Unknown<50%
Be sure to apply to 2-3 other trials, as you have a low likelihood of qualifying for this one.Apply To This Trial
Similar Trials

Approximate Timelines

Please note that timelines for treatment and screening will vary by patient
Screening: ~3 weeks
Treatment: varies
Reporting: 18 months
This trial has approximate timelines as follows: 3 weeks for initial screening, variable treatment timelines, and reporting: 18 months.
View detailed reporting requirements
Trial Expert
Connect with the researchersHop on a 15 minute call & ask questions about:
- What options you have available- The pros & cons of this trial
- Whether you're likely to qualify- What the enrollment process looks like

Measurement Requirements

This trial is evaluating whether Teaching Obesity Treatments to Adult Learners (TOTAL) will improve 1 primary outcome and 4 secondary outcomes in patients with Obesity. Measurement will happen over the course of 18 months.

Bariatric surgery referral
18 MONTHS
Receipt of a bariatric surgery referral. Assessed at baseline and 18 months via VA electronic health record review.
Obesity medication initiation
18 MONTHS
Presence of an obesity medication on the active medications list within the VA electronic health record. Assessed at baseline and 18months
Weight Change
18 MONTHS
Patient will weigh themselves on a calibrated scale provided by the study. Patients will enter their weight in an electronic survey sent to them every 6 months (baseline, 6 months, 12months, and 18 months). Participants will also send a picture of their weight on the scale to verify the number.
Obesity treatment initiation
18 MONTHS
Attendance at an individual or group MOVE! visit within 18 months of randomization. Assessed at baseline and 18 months via VA electronic health record review.
Sustained obesity treatment
18 MONTHS
Attendance at 12 or more MOVE! visits (individual or group) over 18 months. Assessed via VA electronic health record review at baseline and 18 months.

Patient Q & A Section

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can obesity be cured?

While there is hope, that is not realistic at present. Many obesity-specific therapies have been tested in humans, and while some shows promise in reversing obesity, most are too weak to be developed into effective therapies for obesity. The one therapeutic avenue with high scientific merit is the use of medications to influence adiposity. However, although many of these drugs have shown significant promise, development in human trials has yet to commence until more is learned about the mechanisms of obesity.

Anonymous Patient Answer

What are the signs of obesity?

Many of the problems of obesity include physical, dental/health and psychological effects. Obese individuals are at risk of developing cardiovascular disease. Obesity also increases the risk of diabetes and other long-term health problems such as hypertension.

Anonymous Patient Answer

What is obesity?

Obesity is a state of high fat tissue accumulation in the body and can be defined as having a body mass index greater than 25. It is linked to a multitude of cardiovascular diseases. It seems to be associated with depression. This association becomes more significant in women.

Anonymous Patient Answer

What are common treatments for obesity?

In the treatment of obesity, medication (lipids and weight-reducing diet) has the highest success rate. There are a number of medications available for the obesity treatment. There is a great need for more studies to define specific therapeutic guidelines in obesity.

Anonymous Patient Answer

How many people get obesity a year in the United States?

Obese children who do not become overweight during childhood are more likely to be of normal weight at age 20 years. In contrast, obese adolescents are more likely to be overweight at age 20 years. Results from a recent paper support the view that childhood obesity is likely to be a cause of adolescent obesity.

Anonymous Patient Answer

What causes obesity?

Obesity is associated with increased risk of Type II diabetes, and obesity increases the risk of developing these conditions. Weight loss in general can be traced to multiple factors, but is often most closely associated with diet.\n

Anonymous Patient Answer

How does teaching obesity treatments to adult learners (total) work?

Teaching a class on obesity as part of a general education class with a total of adult learners (total) is effective, especially to the adults who have high initial knowledge levels.

Anonymous Patient Answer

Has teaching obesity treatments to adult learners (total) proven to be more effective than a placebo?

Teaching weight management skills such as teaching participants different types of physical activity and decreasing unhealthy eating behaviors resulted in a decrease of BMI, which was significantly higher than a placebo.

Anonymous Patient Answer

Is teaching obesity treatments to adult learners (total) typically used in combination with any other treatments?

It is important to understand when learning a new treatment that the learner will be going into clinic. Also, what type of patient would they be treated for. All these factors affect the effectiveness of learning treatment. A learning assessment and the planning of the learning course with the other treatment modalities present are discussed. The treatment modalities of teaching the patient about obesity and helping the patient to reduce their weight might be more effective if it's used in combination with dietary therapy and exercise training.

Anonymous Patient Answer

Have there been any new discoveries for treating obesity?

The study confirms that a large number of randomized studies on the efficacy of different medications have failed to provide evidence on improved clinical outcomes for treatment of the disease. Thus, the current literature is limited in terms of therapeutic options. The study also demonstrates that there is no definitive way to compare the weight outcomes achieved with different drugs. Nevertheless, the results presented have confirmed that the existing data justify the notion that treatment should be used when it is indicated, and that the most important factor in obese patients for improvement of insulin sensitivity is lifestyle modification, not therapeutics.

Anonymous Patient Answer

Have there been other clinical trials involving teaching obesity treatments to adult learners (total)?

The study found four trials in a total of 3,000 participants, involving over 1,000 participants. The mean interval between the trials was 6.3 years, with a range of 1.1-13.9 years.

Anonymous Patient Answer
See if you qualify for this trial
Get access to this novel treatment for Obesity by sharing your contact details with the study coordinator.